Trevena Company
Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Headquarters:
King Of Prussia, Pennsylvania, United States
Technology:
Cancer
Estimated Revenue:
$1M to $10M
Founded Date:
2007
Industry:
PharmTech